这是一篇来自已证抗体库的有关
人类 SGCG的综述，是根据5篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合SGCG 抗体。
SGCG 同义词: 35DAG; DAGA4; DMDA; DMDA1; LGMD2C; MAM; SCARMD2; SCG3; gamma-SG; gamma-sarcoglycan; 35 kDa dystrophin-associated glycoprotein; 35kD dystrophin-associated glycoprotein; sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
武汉三鹰
| 兔 多克隆 | - 免疫组化-冰冻切片; 人类; 1:400; 图 4
| 武汉三鹰 SGCG抗体（Proteintech, 18102-1AP)被用于被用于免疫组化-冰冻切片在人类样品上浓度为1:400 (图 4). PLoS ONE (2016) ncbi |
丹科医疗器械技术服务（上海）有限公司
| 小鼠 单克隆（DAK-H1-WT） | | 丹科医疗器械技术服务（上海）有限公司 SGCG抗体（Dako, M7298)被用于被用于免疫组化-石蜡切片在人类样品上 (图 1). Oncotarget (2017) ncbi |
| 小鼠 单克隆（DAK-H1-WT） | | 丹科医疗器械技术服务（上海）有限公司 SGCG抗体（Dako, M7298)被用于被用于免疫印迹在人类样品上 (图 3). Int J Oncol (2015) ncbi |
徕卡显微系统(上海)贸易有限公司
| 小鼠 单克隆（35DAG/21B5） | | 徕卡显微系统(上海)贸易有限公司 SGCG抗体（Leica Biosystems, 35DAG/21B5)被用于被用于免疫印迹基因敲除验证在小鼠样品上 (图 1a). Biochem Biophys Res Commun (2017) ncbi |
| 小鼠 单克隆（35DAG/21B5） | - 免疫组化-冰冻切片; 小鼠; 1:250; 图 6
| 徕卡显微系统(上海)贸易有限公司 SGCG抗体（NovaCastra, NCL-g-sarc)被用于被用于免疫组化-冰冻切片在小鼠样品上浓度为1:250 (图 6). elife (2016) ncbi |
Fukai Y, Ohsawa Y, Ohtsubo H, Nishimatsu S, Hagiwara H, Noda M,
et al. Cleavage of ?-dystroglycan occurs in sarcoglycan-deficient skeletal muscle without MMP-2 and MMP-9. Biochem Biophys Res Commun. 2017;492:199-205
pubmed 出版商 Khelwatty S, Essapen S, Bagwan I, Green M, Seddon A, Modjtahedi H. The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer. Oncotarget. 2017;8:7666-7677
pubmed 出版商 Vanhoutte D, Schips T, Kwong J, Davis J, Tjondrokoesoemo A, Brody M,
et al. Thrombospondin expression in myofibers stabilizes muscle membranes. elife. 2016;5:
pubmed 出版商 Janghra N, Morgan J, Sewry C, Wilson F, Davies K, Muntoni F,
et al. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies. PLoS ONE. 2016;11:e0150818
pubmed 出版商 Hole S, Pedersen A, Hansen S, Lundqvist J, Yde C, Lykkesfeldt A. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane. Int J Oncol. 2015;46:1481-90
pubmed 出版商
